Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Proliferative vitreoretinopathy on SS-OCT
Author Affiliations & Notes
  • Isabela Martins Melo
    St Michael's Hospital, Toronto, Ontario, Canada
  • Saba Samet
    St Michael's Hospital, Toronto, Ontario, Canada
  • Aurora Pecaku
    St Michael's Hospital, Toronto, Ontario, Canada
  • Sue Ellen Demian
    St Michael's Hospital, Toronto, Ontario, Canada
  • Miguel Nicolas Cruz Pimentel
    St Michael's Hospital, Toronto, Ontario, Canada
  • Rajeev Hemant Muni
    St Michael's Hospital, Toronto, Ontario, Canada
  • Footnotes
    Commercial Relationships   Isabela Martins Melo None; Saba Samet None; Aurora Pecaku None; Sue Demian None; Miguel Nicolas Cruz Pimentel None; Rajeev Muni None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 6484. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Isabela Martins Melo, Saba Samet, Aurora Pecaku, Sue Ellen Demian, Miguel Nicolas Cruz Pimentel, Rajeev Hemant Muni; Proliferative vitreoretinopathy on SS-OCT. Invest. Ophthalmol. Vis. Sci. 2024;65(7):6484.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To describe the microstructural changes in proliferative vitreoretinopathy(PVR) detected on baseline swept-source optical coherence tomography(SS-OCT) in rhegmatogenous retinal detachment(RRD).

Methods : A prospective cohort of primary RRDs, presenting to St. Michael’s Hospital from January 2020-July 2023, were assessed at presentation for signs of PVR. Posterior pole or ultra-widefield SS-OCT was graded for predominant type of PVR (pre, intra or subretinal), and associated retinal abnormalities were characterized.

Results : Forty-three patients had signs of PVR on baseline SS-OCT, of which 67%(29/43) were male, mean age of 55.8 years old, and 72%(31/43) were phakic. Mean baseline logMAR vison was 1.2 with a duration of fovea-off of 45.4 days and RRD extent of 7.3 clock hours. Of those, 65.3%(28/43) presented with subretinal PVR and 34.7%(15/43) presented with intra-retinal PVR detected with OCT. Pre-retinal PVR was only observed together with the intra-retinal type. Sub-retinal PVR appears on SS-OCT as a hyperreflective line in contact with the neurosensory retina or as an amorphous band over the RPE. The former may cause folding of the outer retina if photoreceptor segments are still intact or extend over areas of photoreceptor loss if there is retinal thinning and signs of atrophy. Subretinal PVR was significantly associated with shallow regulated RRDs on clinical examination. In contrast, intra-retinal PVR was associated with bullous dysregulated RRDs, and it was only noticed in patients with concurrent outer retinal corrugations. Intra-retinal PVR is observed as a thickening of the inner retina with disorganization of retinal layers, with folding of both the inner and outer retina. Initial signs of intraretinal PVR were noticed in areas of RRD baseline morphologic stage 4, where ORCs were fused together, leading to outer retinal folds. On the contrary, subretinal PVR was associated with RRD morphologic baseline stage 5.

Conclusions : We present a novel conceptual framework for PVR in RRD based on OCT. The type of PVR observed was associated with baseline RRD clinical status (regulated vs dysregulated), per Muni et al 2022. PVR formation seems to be associated with a proliferative pathway (when intra-retinal) vs an apoptotic/atrophic pathway (when subretinal). Recognizing the spectrum of morphological changes on OCT may assist with early and accurate diagnosis of PVR and allow for improved assessment of the efficacy of novel therapeutic agents.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×